202503.10
29

Abstract Theory not supported by Scientific Evidence lacks Novelty and Inventive Step

C.A.(COMM.IPD-PAT) 4/2025, I.A. 3780/2025 & I.A. 3781/2025 Delhi High Court The appellants through this Appeal before the Delhi High Court sought to overturn a decision by the Assistant Controller of Patents and Designs refusing their patent application, titled “Innovative Change To Solve Any Dispute, Unexpected Business Loss, Closures, Financial Loss, Unexpected Accidents,”. The application was…

202502.17
29

India – Legal Landscape for Gaming Industry

Q1: How does the Indian legal system differentiate between games of chance and games of skill? The Indian courts have used the “dominant factor test” or “predominant test” to determine whether skill or chance plays a predominant part in determining the result of the game. Games based on skill are kept out of the purview…

202502.03
30

Music composer has no right to license Musical Rights

Background of the Case Saregama India Limited (Saregama) filed a suit against Vels Film International Limited (Defendant no 1) and others, at the Delhi High Court, for infringing its copyright in the song “En Iniya Pon Nilave” from the film “Moodu Pani” by using it in the film “Aghathiyaa”. Saregama claimed ownership of the song…

202501.20
29

Revocation Petition Maintainable though no Live Patent Subsisting

I.A. 7635/2024 and I.A. 46685/2024IN C.O.(COMM.IPD-PAT) 38/2022 Background The Petitioner, Macleods Pharmaceuticals Ltd., is engaged in manufacturing and marketing diverse pharmaceutical products, including anti-diabetic drugs. The Respondent no. 2, Boehringer Ingelheim Pharma GmbH & Co. KG, is a company organized under the laws of Germany and is involved in developing, manufacturing, and marketing pharmaceuticals worldwide,…

202501.09
29

Delhi High Court Cancels Trademark and Copyright Registrations for “PHENSERYL”

The Delhi High Court has ruled in favor of Opella Healthcare Group (“Petitioner”) in its bid to protect its mark “PHENSEDYL.” The dispute revolved around the Respondent’s (Vaibhav) mark “PHENSERYL” and its associated artistic work, which the Petitioner argued were deceptively similar to their well-known trademark. The Petitioner has also obtained an injunction from the…

202412.30
29

IP firm seeks to restrain former employees from disclosing confidential information

The case highlights that apart from claims of ‘trade secrets’ and ‘confidential information’ the attorneys working with a law firm are bound by attorney client communication being privileged and cannot be divulged to a third party under any circumstances. Sharing such information and communication would not only be unethical but also a breach of the…

202412.26
28

Zydus Wins Injunction Against Alder in “BIOCHEM” Trademark Case

Zydus Healthcare Ltd. (“Zydus”) and Alder Biochem Pvt. Ltd. (“Alder”) are at loggerheads over the mark BIOCHEM. Zydus brought trademark infringement and passing-off lawsuit against Alder’s use of the mark ALDER BIOCHEM as its trade name. Zydus alleged that a) Alder’s use violated its intellectual property rights over the trademark BIOCHEM b) Alder’s adoption of…

202412.18
28

Realistic costs ought to be awarded considering ever-increasing litigation expenses

Facts and Background The Plaintiffs, AstraZeneca, filed a suit (CS (Comm.) 101/2022) at the Delhi High Court seeking a permanent injunction to restrain the Defendant, Westcoast Pharmaceutical Works Limited from infringing their patent IN 297581. The Patent was for the novel compound Osimertinib, used for treating specific types of non-small cell lung cancer. In January…